3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)Primary Membranous NephropathyRecruitingPhase 2 / Phase 32026-09-18NCT07204275
Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical TrialCerebral Small Vessel Diseases, Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Stroke, Lacunar, Thrombotic Stroke, brain disorder, brain infarction, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorderRecruitingPhase 42026-08-04NCT07111559
Atrasentan in Patients With IgA NephropathyChronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, autoimmune disease, chronic renal failure syndrome, glomerulonephritis, immune system disorder, kidney disorder, kidney failure, nephritis, urinary system disorderActive, not recruitingPhase 32026-06-04NCT04573478